✦ LIBER ✦

Interferon-α in Oncology Patients: Fewer Psychiatric Side Effects Than Anticipated

✍ Scribed by Marjolein Bannink; Wim H.J. Kruit; Arthur R. Van Gool; Stefan Sleijfer; Bronno van der Holt; Alexander M.M. Eggermont; Gerrit Stoter; Michiel W. Hengeveld

Book ID: 117969530
Publisher: American Psychiatric Publishing Inc
Year: 2008
Tongue: English
Weight: 139 KB
Volume: 49
Category: Article
ISSN: 1545-7206
DOI: 10.1176/appi.psy.49.1.56

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incidence of psychiatric side effects du

Incidence of psychiatric side effects during pegylated interferon- α retreatment in nonresponder hepatitis C virus-infected patients

✍ Lucas C. Quarantini; Rodrigo A. Bressan; Amanda Galvão; Susana Batista-Neves; Ra 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Pulmonary side effects of interferon-α t

Pulmonary side effects of interferon-α therapy in patients with hematological malignancies

✍ Patrik Anderson; Martin Höglund; Stig Rödjer 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 1 views

## Abstract Several side effects of interferon‐α‐2b (IFN‐α) therapy have been described. Pulmonary side effects have seldom been reported. The four patients we describe all developed respiratory disorders while being treated with IFN‐α for hematological malignancies. We point out the similarities a

Hepatitis C treatment in “difficult-to-t

Hepatitis C treatment in “difficult-to-treat” psychiatric patients with pegylated interferon-alpha and ribavirin: Response and psychiatric side effects

✍ Martin Schaefer; Axel Hinzpeter; Ariane Mohmand; Gesa Janssen; Maurice Pich; Mar 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 1 views

We investigated and compared the results of treating the chronic hepatitis C (HCV) infection of different groups of psychiatric-risk patients and controls with pegylated interferon alpha (pe-gIFN-␣) plus ribavirin. Seventy patients were prospectively screened for psychiatric disorders. Seventeen pat

Psychiatric side effects during combinat

Psychiatric side effects during combination treatment for chronic hepatitis C with interferon-α and ribavirin in psychiatric risk groups—A prospective and controlled study

✍ Schaefer, Martin; Schmidt, Folkard; Soyka, Michael; Lorenz, Reinhard; Loeschke, 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 365 KB

Practical guidelines for the management

Practical guidelines for the management of interferon-α-2b side effects in patients receiving adjuvant treatment for melanoma : Expert opinion

✍ Axel Hauschild; Helen Gogas; Ahmad Tarhini; Mark R. Middleton; Alessandro Testor 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

## Abstract Interferon‐α‐2b (IFNα2b) is the only effective adjuvant therapy for melanoma patients at high risk of recurrence that has been approved by regulatory authorities worldwide. However, IFN toxicities increase the risk of poor treatment compliance and impair the potential for benefit from t